Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid Dosing in Pediatric Cardiac Surgery
NCT01141127Phase 2Completed
- Sponsor
- Hôpital Marie-Lannelongue
- Start
- Jun 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of tranexamic acid in hemorrhage (2 arms), sponsored by Hôpital Marie-Lannelongue. Primary endpoint: Preoperative plasma tranexamic acid concentration at 24 hours. Started Jun 2010; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT01141127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01141127.